Related Experiment Video
Updated: Aug 27, 2025
06:04
Author Spotlight: Studying Clinical Characters and Epilepsy Outcomes After Frontal Disconnection in Patients with MOGHE
Published on: August 16, 2024
1.0K
[Moyamoya disease in children]
Radek Frič1, Angelika Sorteberg2, Sean Wallace3
1Nevrokirurgisk avdeling, Nevroklinikken, Oslo universitetssykehus, Rikshospitalet.
Summary
Moyamoya disease is a rare brain vascular condition in children and young adults that can cause stroke. Early diagnosis and treatment, including surgery, improve outcomes but require specialized medical care.
Area of Science:
- Neurology
- Pediatric Neurology
- Vascular Neurology
Background:
- Moyamoya disease is a rare, progressive cerebrovascular disorder.
- It primarily affects children and young adults, leading to ischemic stroke and cerebral hemorrhage.
- Despite diagnostic criteria, misdiagnosis or delayed diagnosis is common due to limited awareness.
Purpose of the Study:
- To highlight the diagnostic challenges and treatment strategies for Moyamoya disease.
- To emphasize the importance of early recognition and intervention.
- To discuss the prognosis and management requirements for this condition.
Main Methods:
- Review of established diagnostic criteria for Moyamoya disease.
- Analysis of current treatment modalities, including antiplatelet therapy and surgical revascularization.
- Evaluation of patient outcomes and prognostic factors.
Main Results:
- Moyamoya disease presents with significant risks of stroke (ischemic and hemorrhagic).
- Delayed diagnosis is a frequent issue, impacting patient management.
- Surgical revascularization offers a good prognosis when performed successfully.
Conclusions:
- Moyamoya disease necessitates prompt diagnosis and specialized management.
- Effective treatment, particularly surgical intervention, can lead to favorable outcomes.
- A dedicated multidisciplinary team is crucial for optimal patient care.
Related Concept Videos
01:17Ischemic Heart Disease: Overview
1.4K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K
01:30Coronary Artery Disease III: Clinical Manifestations
25
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
25
01:22Mitral Stenosis I: Introduction
27
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
27
01:26Coronary Artery Disease II: Pathophysiology
25
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
25
01:23Mitral Stenosis II: Clinical features and Diagnostic Tests
31
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
31
01:21Aneurysm II: Clinical Manifestations and Diagnostic Studies
19
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
19